Whitehawk Therapeutics (WHWK) Operating Income Growth (3y) (2013 - 2026)
Whitehawk Therapeutics (WHWK) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 55.96% |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | -11.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.82% |
| Dec 31, 2025 | -17.17% |
| Sep 30, 2025 | -9.14% |
| Jun 30, 2025 | -43.94% |
| Mar 31, 2025 | -3.28% |
| Dec 31, 2024 | -5.92% |
| Sep 30, 2024 | 46.44% |
| Jun 30, 2024 | -59.03% |
| Mar 31, 2024 | -68.38% |
| Dec 31, 2023 | -60.15% |
| Sep 30, 2023 | -88.54% |
| Jun 30, 2023 | -60.20% |
| Mar 31, 2023 | -59.91% |
| Dec 31, 2022 | -49.21% |
| Sep 30, 2022 | -44.66% |
| Jun 30, 2022 | -45.35% |
| Mar 31, 2022 | -16.04% |
| Dec 31, 2021 | -21.61% |
| Sep 30, 2021 | -113.98% |
| Jun 30, 2021 | 13.74% |